These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


465 related items for PubMed ID: 31328444

  • 1. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
    Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG.
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
    [Abstract] [Full Text] [Related]

  • 2. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG.
    Trials; 2021 Jul 26; 22(1):489. PubMed ID: 34311754
    [Abstract] [Full Text] [Related]

  • 3. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E, Sikkema KJ, Julies RF, Mazer K, O'Malley G, Heffron R, Morton JF, Johnson R, Celum C, Baeten JM, Bekker LG.
    J Int AIDS Soc; 2024 May 26; 27(5):e26254. PubMed ID: 38695101
    [Abstract] [Full Text] [Related]

  • 4. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, Kudrick L, Anderson PL, Haberer JE, Wu L, Heffron R, Johnson R, Morrison S, Baeten JM, POWER Study Team.
    J Int AIDS Soc; 2022 Jul 26; 25(7):e25962. PubMed ID: 35822945
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, Dettinger JC, John-Stewart G, Baeten JM, PrEP Implementation for Young Women and Adolescents (PrIYA) Program.
    PLoS Med; 2019 Sep 26; 16(9):e1002885. PubMed ID: 31479452
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK, Pintye J, Harrington E, Houck S, Kwena Z, Lenn M, Mogaka F, Momanyi V, Mugambi M, Nyerere B, Odoyo J, Omollo V, Ortblad KF, Rota G, Sharma M, Bukusi EA.
    Trials; 2024 Jun 19; 25(1):394. PubMed ID: 38890744
    [Abstract] [Full Text] [Related]

  • 11. Integrating a mental health intervention into PrEP services for South African young women: a human-centred implementation research approach to intervention development.
    Velloza J, Ndimande-Khoza N, Mills L, Concepcion T, Gumede S, Chauke H, Verhey R, Chibanda D, Hosek S, Weiner BJ, Celum C, Delany-Moretlwe S.
    J Int AIDS Soc; 2024 Jul 19; 27 Suppl 1(Suppl 1):e26274. PubMed ID: 38965973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J, Larsen AM, Kinuthia J, Owiti G, Abuna F, Kohler PK, John-Stewart G, Pintye J.
    AIDS Patient Care STDS; 2020 Aug 19; 34(8):336-343. PubMed ID: 32757980
    [Abstract] [Full Text] [Related]

  • 14. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
    Velloza J, Hosek S, Donnell D, Anderson PL, Chirenje M, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C, HPTN 082 study group.
    J Int AIDS Soc; 2021 Jun 19; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa.
    Giovenco D, Pettifor A, Powers KA, Hightow-Weidman L, Pence BW, Edwards JK, Gill K, Morton JF, van der Straten A, Celum C, Bekker LG.
    AIDS Behav; 2022 Apr 19; 26(4):1007-1016. PubMed ID: 34478015
    [Abstract] [Full Text] [Related]

  • 17. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
    Roche SD, Barnabee G, Omollo V, Mogaka F, Odoyo J, Bukusi EA, Morton JF, Johnson R, Celum C, Baeten JM, O'Malley G.
    BMC Health Serv Res; 2022 Mar 30; 22(1):422. PubMed ID: 35354456
    [Abstract] [Full Text] [Related]

  • 18. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, Chinyenze K, Kuteesa M, Kaleebu P, Price MA.
    J Int AIDS Soc; 2022 May 30; 25(5):e25909. PubMed ID: 35543110
    [Abstract] [Full Text] [Related]

  • 19. Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.
    Medina-Marino A, Bezuidenhout D, Ngwepe P, Bezuidenhout C, Facente SN, Mabandla S, Hosek S, Little F, Celum CL, Bekker LG.
    J Int AIDS Soc; 2022 Jul 30; 25(7):e25968. PubMed ID: 35872602
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.